Major Force in the Orlistat Market 2025: Rising Obesity Rates And Their Impact On The Growth Of The Orlistat Market

How Will the Orlistat Market Grow, and What Is the Projected Market Size?
Over the past few years, the market size of orlistat has expanded significantly. The projection shows an increase from $3.03 billion in 2024 to $3.24 billion in 2025 with a compound annual growth rate (CAGR) of 6.7%. The increase in previous years could be due to factors like heightened knowledge about the health risks connected with obesity, sanctioning of orlistat as a prescription drug, accessibility of orlistat over-the-counter in lesser doses, recommendations by physicians, and the escalating expenses of healthcare related to obesity.

The market for orlistat is predicted to experience robust growth in the upcoming years, anticipating to reach a staggering $4.15 billion by 2029, showcasing a compound annual growth rate (CAGR) of 6.4%. This expected surge during the forecast period is attributed to factors such as increased health-care expenditure on obesity treatments, the prevalence of sedentary lifestyles and unhealthy dietary habits, government initiatives encouraging weight reduction and good health, the growing elderly population, and the transition from prescription to over-the-counter medications. The imminent trends in the predicted period involve AI-infused diet plans, telemedicine services, automated devices reminding patients about medication and tracking compliance, virtual reality-based fitness routines, and digital therapeutics.

What Key Elements Are Boosting Growth in the Orlistat Market?
Rising rates of obesity are predicted to fuel the expansion of the orlistat market in the future. Obesity, a health condition marked by an excess buildup of body fat that can harm one's health, is typically identified with a body mass index (BMI) of 30 or above. The escalation in obesity can be attributed to factors like unhealthy eating habits, insufficient physical exercise, and stationary lifestyles. Orlistat plays a significant role in the management of obesity, working by hampering the assimilation of dietary fats, thereby facilitating weight reduction and the maintenance of weight loss. It's often dispensed in tandem with a low-calorie diet and regular physical activity for enhanced outcomes. The World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in March 2022 that obesity plagued over 1 billion people worldwide, including 650 million adults, 340 million teenagers, and 39 million children. This statistic continues to ascend and by 2025, it's estimated that approximately 167 million people, comprising both adults and children, will suffer from deteriorating health conditions resulting from overweight or obesity. Consequently, the escalating rates of obesity are propelling the growth of the orlistat market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp

Who Are the Major Industry Players Fueling Orlistat Market Expansion?
Major companies operating in the orlistat market are Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Roche Holding AG, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd.

Which Key Developments Are Influencing the Orlistat Market?
Leading organizations in the orlistat marketplace are revolutionizing their product suite with inventions such as weight reduction pharmaceuticals which are set to amplify personal hygiene and convenience through cutting-edge design and technology. These medications aim to assist people in lessening body weight by curbing appetite, augmenting metabolism or obstructing the absorption of fat. To illustrate, in November 2023, the US-based Eli Lilly and Company secured approval from the US Food and Drug Administration (FDA) for the launch of Zepbound (tirzepatide) injection, an innovative weight loss product. This medication is the inaugural and only authorised treatment that triggers two incretin hormone receptors, namely GIP and GLP-1, thereby addressing a primary source of excessive weight. Zepbound is recommended for consistent weight management in adults with obesity (BMI =30 kg/m²) or those who are overweight (BMI =27 kg/m²) with at least one weight-related health issue, as a complement to a reduced-calorie diet and intensified physical exertion.

How Is the Segmentation of the Orlistat Market Defined?
The orlistat market covered in this report is segmented -

1) By Type: 120 Milligram (Mg), 60 Milligram(Mg)
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Weight-Reducing Aid, Other Applications

Subsegments:
1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat, Over-The-Counter (OTC) 120 Mg Orlistat
2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat, Prescription-Based 60 Mg Orlistat

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report

What Is the Leading Region in the Orlistat Market?
North America was the largest region in the orlistat market in 2023. The regions covered in the orlistat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Orlistat Global Market Report?

- Market Size Analysis: Analyze the Orlistat Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Orlistat Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Orlistat Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Orlistat Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18422

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.